Flagship Capital Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$394K Buy
2,712
+15
+0.6% +$2.07K 0.24% 37
2026
Q2
$347K Buy
2,697
+5
+0.2% +$585 0.22% 42
2026
Q1
$324K Sell
2,692
-379
-12% -$43.8K 0.24% 40
2025
Q4
$323K Buy
+3,071
New +$288K 0.23% 40

Other funds holding MRK

Flagship Capital Management's MRK Position: Q3 2026 in Review

Flagship Capital Management increased its Merck (MRK) stake by 0.56% in Q3 2026, buying an estimated $2.07K and bringing the position to 2,712 shares worth $394K. The position accounts for 0.24% of the portfolio, ranked #37.

Flagship Capital Management first reported a position in MRK in Q4 2025 and has held it in 4 quarters since. 2,447 funds tracked by Wall St. Rank hold MRK as of Q3 2026.

  • Flagship Capital Management held 2,712 shares of Merck worth $394K as of Q3 2026.
  • Flagship Capital Management bought 15 Merck shares in Q3 2026, an estimated $2.07K.
  • Merck made up 0.24% of Flagship Capital Management's portfolio in Q3 2026, its #37 holding.
  • Flagship Capital Management first reported a position in Merck in Q4 2025 and has held it in 4 quarters since.
  • 2,447 funds tracked by Wall St. Rank held Merck as of Q3 2026.

Based on Flagship Capital Management's 13F filing for Q3 2026, filed 20 Oct 2026.